AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure's Isolatoru00ae Synergyu2122 Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure's AtriClipu00ae Left Atrial Appendage Exclusi...